Does TENOFOVIR DISOPROXIL Cause Hepatic function abnormal? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Hepatic function abnormal have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 0.3% of all adverse event reports for TENOFOVIR DISOPROXIL.
77
Reports of Hepatic function abnormal with TENOFOVIR DISOPROXIL
0.3%
of all TENOFOVIR DISOPROXIL reports
5
Deaths
43
Hospitalizations
How Dangerous Is Hepatic function abnormal From TENOFOVIR DISOPROXIL?
Of the 77 reports, 5 (6.5%) resulted in death, 43 (55.8%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?
Bone density decreased (10,586)
Renal injury (9,255)
Skeletal injury (8,320)
Chronic kidney disease (7,230)
Osteonecrosis (7,182)
Bone loss (7,040)
Multiple fractures (6,793)
Renal failure (6,388)
Osteoporosis (5,302)
Tooth loss (4,483)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which TENOFOVIR DISOPROXIL Alternatives Have Lower Hepatic function abnormal Risk?
TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV
TENOFOVIR DISOPROXIL vs TEPOTINIB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW
TENOFOVIR DISOPROXIL vs TERAZOSIN